ALBT vs. ATIF, RVYL, AIM, PMCB, EVAX, IKT, SNTI, APTO, COEP, and CLDI
Should you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include ATIF (ATIF), Ryvyl (RVYL), AIM ImmunoTech (AIM), PharmaCyte Biotech (PMCB), Evaxion Biotech A/S (EVAX), Inhibikase Therapeutics (IKT), Senti Biosciences (SNTI), Aptose Biosciences (APTO), Coeptis Therapeutics (COEP), and Calidi Biotherapeutics (CLDI).
ATIF (NASDAQ:ATIF) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking.
In the previous week, ATIF had 7 more articles in the media than Avalon GloboCare. MarketBeat recorded 10 mentions for ATIF and 3 mentions for Avalon GloboCare. ATIF's average media sentiment score of 1.28 beat Avalon GloboCare's score of 0.17 indicating that Avalon GloboCare is being referred to more favorably in the news media.
ATIF received 34 more outperform votes than Avalon GloboCare when rated by MarketBeat users.
ATIF has a net margin of -1,017.40% compared to ATIF's net margin of -1,173.55%. ATIF's return on equity of 0.00% beat Avalon GloboCare's return on equity.
ATIF has a beta of -0.39, suggesting that its share price is 139% less volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of 0.32, suggesting that its share price is 68% less volatile than the S&P 500.
ATIF has higher revenue and earnings than Avalon GloboCare. ATIF is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks.
1.4% of Avalon GloboCare shares are held by institutional investors. 32.2% of ATIF shares are held by insiders. Comparatively, 64.0% of Avalon GloboCare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
ATIF and Avalon GloboCare tied by winning 7 of the 14 factors compared between the two stocks.
Get Avalon GloboCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Avalon GloboCare Competitors List
Related Companies and Tools
